This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
inflation: Archive
Time to Buy JPMorgan & Citigroup Stock for Potential Rate Cuts
by Shaun Pruitt
With investors starting to clamor for a September rate cut, the outlook for JPMorgan and Citigroup may become even more appealing thanks to their strong capital positions.
dividends earnings finance inflation interest-rate investing large-cap
Rate-Cut Bonanza Keeps Markets at Record Highs
by Mark Vickery
Market participants continue to ride the narrative that interest rate cuts will be coming down.
earnings inflation interest-rate tech-stocks
Pre-Markets Up on Rate-Cut Excitement
by Mark Vickery
Right now we're looking at 2-3 rate cuts for the remainder of 2025; this roughly would equate a 3.50-3.75% Fed funds rate by the end of the year.
earnings inflation interest-rate
ADP, GDP & FOMC: Alphabet Soup of Market Data
by Mark Vickery
Both ADP jobs and Q2 GDP outperformed estimates this morning. The FOMC meeting concludes later today.
earnings inflation interest-rate staffing
Big Week for Jobs, Earnings and the Fed
by Mark Vickery
There's only a 2% chance the Fed has enough votes to cut to outstrip Fed Chair Powell's opinion to keep interest rates where they are.
earnings finance inflation interest-rate staffing
Markets Fight Off Powell Rumor, Close in the Green
by Mark Vickery
A report that President Trump intended on firing Fed Chair Jerome Powell sent all major indexes into the loss column temporarily.
airlines earnings industrial-products inflation interest-rate
Strong Q2 Earnings, Cooling PPI Lead Pre-Markets Higher
by Mark Vickery
Headline PPI for June, month over month, reached 0.0% -- lower than the +0.2% expected and 30 bps below May.
banking earnings inflation pharmaceuticals
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
by Shaun Pruitt
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
dividend-investing dividends earnings inflation investing large-cap medical medical-devices pharmaceuticals
Markets Hit Record Highs, Banks Report Q2 Results: Stocks to Watch
by Bryan Hayes
Positive earnings results out of the gate bode well for the remainder of the season.
artificial-intelligence earnings finance inflation investing semiconductor tech-stocks
Big Week of Inflation Data, Q2 Earnings Reports
by Mark Vickery
Not only do we look forward to the biggest of the Wall Street banks reporting Q2 earnings, but a whole host of economic prints, including a fresh Inflation Rate for the month of June, are expected.
banking earnings finance industrial-products inflation